ASCT2-mediated glutamine uptake of epithelial cells facilitates CCL5-induced T cell infiltration via ROS-STAT3 pathway in oral lichen planus.

[1]  K. Park,et al.  Targeting glutamine metabolism as a therapeutic strategy for cancer , 2023, Experimental & molecular medicine.

[2]  Qianming Chen,et al.  Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment , 2023, Frontiers in Immunology.

[3]  A. Herrmann,et al.  STAT proteins in cancer: orchestration of metabolism , 2023, Nature Reviews Cancer.

[4]  Jingyi Lu,et al.  Glutamine promotes the proliferation of epithelial cells via mTOR/S6 pathway in oral lichen planus. , 2022, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[5]  Y. Duan,et al.  Glutamine metabolism in cancers: Targeting the oxidative homeostasis , 2022, Frontiers in Oncology.

[6]  M. Jiang,et al.  STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma , 2022, Cells.

[7]  Haitao Niu,et al.  Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment , 2022, Cell Communication and Signaling.

[8]  Chenyu Zhou,et al.  FAP‐α+ immunofibroblasts in oral lichen planus promote CD4+ T‐cell infiltration via CCL5 secretion , 2022, Experimental dermatology.

[9]  R. V. Dúran,et al.  Glutamine, MTOR and autophagy: a multiconnection relationship , 2022, Autophagy.

[10]  O. Kujan,et al.  Immunoexpression of oral brush biopsy enhances the accuracy of diagnosis for oral lichen planus and lichenoid lesions , 2022, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[11]  X. Pan,et al.  IL-27 Induces CCL5 Production by T Lymphocytes, Which Contributes to Antitumor Activity , 2022, The Journal of Immunology.

[12]  G. Tsokos,et al.  Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus , 2022, Arthritis & rheumatology.

[13]  W. Guan,et al.  Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma , 2022, Inflammation.

[14]  Mingyue Tan,et al.  Qici Sanling Decoction Suppresses Glutamine Consumption and Bladder Cancer Cell Growth through Inhibiting c-Myc Expression , 2022, Journal of oncology.

[15]  B. Skålhegg,et al.  Identification and characterization of a novel glutaminase inhibitor , 2021, FEBS open bio.

[16]  S. Şenel.  An Overview of Physical, Microbiological and Immune Barriers of Oral Mucosa , 2021, International journal of molecular sciences.

[17]  Qianming Chen,et al.  Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis , 2021, Mucosal Immunology.

[18]  G. Sethi,et al.  Fangchinoline diminishes STAT3 activation by stimulating oxidative stress and targeting SHP-1 protein in multiple myeloma model , 2021, Journal of Advanced Research.

[19]  O. Kujan,et al.  Observer agreement in the diagnosis of oral lichen planus using the proposed criteria of the American Academy of Oral and Maxillofacial Pathology. , 2021, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[20]  In-kyu Lee,et al.  Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity. , 2020, Molecular cell.

[21]  W. Zhou,et al.  GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis. , 2020, The Journal of clinical investigation.

[22]  F. Feng,et al.  Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and future for novel cancer therapy. , 2020, Pharmacological research.

[23]  Yuan Fan,et al.  Potential roles of the CCL17-CCR4 axis in immuno-pathogenesis of oral lichen planus. , 2020, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[24]  Dandan Zhu,et al.  Expression and biological functions of the CCL5‐CCR5 axis in oral lichen planus , 2019, Experimental dermatology.

[25]  L. Zuo,et al.  Spontaneous colitis in IL‐10‐deficient mice was ameliorated via inhibiting glutaminase1 , 2019, Journal of cellular and molecular medicine.

[26]  Yaling Tang,et al.  The maintenance of an oral epithelial barrier. , 2019, Life sciences.

[27]  Yuan Fan,et al.  The Expression of CXCL10/CXCR3 and Effect of the Axis on the Function of T Lymphocyte Involved in Oral Lichen Planus , 2018, Inflammation.

[28]  R. Curi,et al.  Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation , 2018, Nutrients.

[29]  C. Chiang,et al.  Oral lichen planus - Differential diagnoses, serum autoantibodies, hematinic deficiencies, and management. , 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

[30]  Joe T. Sharick,et al.  Pharmacological Blockade of ASCT2-dependent Glutamine Transport Leads To Anti-tumor Efficacy in Preclinical Models , 2017, Nature Medicine.

[31]  J. Qin,et al.  AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis. , 2017, Cancer letters.

[32]  Gerald C. Chu,et al.  Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism , 2017, Nature Communications.

[33]  Qianming Chen,et al.  Role of distinct CD4(+) T helper subset in pathogenesis of oral lichen planus. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[34]  N. Cirillo,et al.  Oral lichen planus: a literature review and update , 2016, Archives of Dermatological Research.

[35]  W. Ritchie,et al.  ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer , 2015, Oncogene.

[36]  P. Gyawali,et al.  Oxidative stress and antioxidant defense in oral lichen planus and oral lichenoid reaction , 2010, Scandinavian journal of clinical and laboratory investigation.

[37]  Jie-shou Li,et al.  Glutamine transporter ASCT2 was down-regulated in ischemic injured human intestinal epithelial cells and reversed by epidermal growth factor. , 2007, JPEN. Journal of parenteral and enteral nutrition.

[38]  Y. Abiko,et al.  Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[39]  H. Ohtani,et al.  Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. , 2003, The American journal of pathology.

[40]  R. Watson,et al.  Oral mucosal keratinocytes express RANTES and ICAM‐1, but not interleukin‐8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings , 2003, Clinical and experimental dermatology.

[41]  D. Pitt,et al.  Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage , 2001, Annals of neurology.

[42]  M. Thornhill,et al.  Immune mechanisms in oral lichen planus , 2001, Acta odontologica Scandinavica.

[43]  M. Thornhill,et al.  Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. , 1996, The Journal of investigative dermatology.

[44]  B. Cheng,et al.  The positive correlation of the CCL2-CCR2 axis with the disease activity may indicate the fundamental role in the pathogenesis of oral lichen planus. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.